Cationic core-shell liponanoparticles for ocular gene delivery

Biomaterials

Volumn 33, Issue 30, 2012, Pages 7621-7630

  Jiang, Min ^a,b   Gan, Li ^a   Zhu, Chunliu ^a   Dong, Yang ^a   Liu, Jianping ^b   Gan, Yong ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Cationic lipids; Chitosan nanoparticles; Core shell; Endocytosis pathway; Lysosome; Transfection

Indexed keywords

CATIONIC LIPIDS; CHITOSAN NANOPARTICLES; CORE-SHELL; ENDOCYTOSIS PATHWAY; LYSOSOME; TRANSFECTION;

CHITOSAN; EXPERIMENTS; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; MOLECULAR BIOLOGY; NANOPARTICLES;

SHELLS (STRUCTURES);

CHITOSAN NANOPARTICLE; DUAL CATIONIC CORE SHELL LIPONANOPARTICLE; ENHANCED GREEN FLUORESCENT PROTEIN; LIPID COATED CHITOSAN NANOPARTICLE; NANOMATERIAL; NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONJUNCTIVA EPITHELIUM; CONTROLLED STUDY; ENDOCYTOSIS; EPITHELIUM CELL; GENE TARGETING; HUMAN; HUMAN CELL; LYSOSOME; MALE; MORPHOLOGY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ZETA POTENTIAL;

ANIMALS; CATIONS; CELL DEATH; CELL SURVIVAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENDOCYTOSIS; EYE; FLUORESCEIN-5-ISOTHIOCYANATE; GENE TRANSFER TECHNIQUES; GREEN FLUORESCENT PROTEINS; HUMANS; LIPIDS; LYSOSOMES; MALE; MICROSCOPY, CONFOCAL; NANOPARTICLES; PARTICLE SIZE; RABBITS; STATIC ELECTRICITY; TRANSFECTION;

ORYCTOLAGUS CUNICULUS;

EID: 84865027958     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.06.079     Document Type: Article

References (52)

1. De Campos A.M., Sánchez A., Gref R., Calvo P., Alonso M.J. The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa. Eur J Pharm Sci 2003, 20:73-81.
2. Kaur I.P., Garg A., Singla A.K., Aggarwal D. Vesicular systems in ocular drug delivery: an overview. Int J Pharm 2004, 269:1-14.
3. Klausner E.A., Peer D., Chapman R.L., Multack R.F., Andurkar S.V. Corneal gene therapy. J Control Release 2007, 124:107-133.
4. Konat Zorzi G., Contreras-Ruiz L., Párraga J.E., López-García A., Romero Bello R., Diebold Y., et al. Expression of MUC5AC in ocular surface epithelial cells using cationized Gelatin nanoparticles. Mol Pharm 2011, 8:1783-1788.
5. de la Fuente M., Raviña M., Paolicelli P., Sanchez A., Seijo B., Alonso M.J. Chitosan-based nanostructures: a delivery platform for ocular therapeutics. Adv Drug Deliver Rev 2010, 62:100-117.
6. Huang M., Ma Z., Khor E., Lim L.Y. Uptake of FITC-chitosan nanoparticles by A549 cells. Pharm Res 2002, 19:1488-1494.
7. Sahay G., Alakhova D.Y., Kabanov A.V. Endocytosis of nanomedicines. J Control Release 2010, 145:182-195.
8. Kim T.H., Kim S.I., Akaike T., Cho C.S. Synergistic effect of poly(ethylenimine) on the transfection efficiency of galactosylated chitosan/DNA complexes. J Control Release 2005, 105:354-366.
9. Chang K.L., Higuchi Y., Kawakami S., Yamashita F., Hashida M. Efficient gene transfection by histidine-modified chitosan through enhancement of endosomal escape. Bioconjug Chem 2010, 21:1087-1095.
10. Huth U.S., Schubert R., Peschka-Süss R. Investigating the uptake and intracellular fate of pH-sensitive liposomes by flow cytometry and spectral bio-imaging. J Control Release 2006, 110:490-504.
11. Vandenbroucke R.E., De Smedt S.C., Demeester J., Sanders N.N. Cellular entry pathway and gene transfer capacity of TAT-modified lipoplexes. Biochim et Biopica Acta (BBA) - Biomembranes 2007, 1768:571-579.
12. Wasungu L., Hoekstra D. Cationic lipids, lipoplexes and intracellular delivery of genes. J Control Release 2006, 116:255-264.
13. Kessner S., Krause A., Rothe U., Bendas G. Investigation of the cellular uptake of E-Selectin-targeted immunoliposomes by activated human endothelial cells. Biochim Biophys Acta 2001, 1514:177-190.
14. Wong A.W., Scales S.J., Reilly D.E. DNA internalized via caveolae requires microtubule-dependent, Rab7-independent transport to the late endocytic pathway for delivery to the nucleus. J Biol Chem 2007, 282:22953-22963.
15. Billiet L., Gomez J.P., Berchel M., Jaffrès P.A., Le Gall T., Montier T., et al. Gene transfer by chemical vectors, and endocytosis routes of polyplexes, lipoplexes and lipopolyplexes in a myoblast cell line. Biomaterials 2012, 33:2980-2990.
16. Wattiaux R., Jadot M., Warnier-Pirotte M.T., Wattiaux-De Coninck S. Cationic lipids destabilize lysosomal membrane in vitro. FEBS Letters 1997, 417:199-202.
17. Pedroso de Lima M.C., Simões S., Pires P., Faneca H., Düzgüneş N. Cationic lipid-DNA complexes in gene delivery: from biophysics to biological applications. Adv Drug Deliver Rev 2001, 47:277-294.
18. Mansouri S., Lavigne P., Corsi K., Benderdour M., Beaumont E., Fernandes J.C. Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy. Eur J Pharm Biopharm 2004, 57:1-8.
19. Hafez I.M., Maurer N., Cullis P.R. On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids. Gene Ther 2001, 8:1188-1196.
20. Behrens I., Pena A.I., Alonso M.J., Kissel T. Comparative uptake studies of bioadhesive and non-bioadhesive nanoparticles in human intestinal cell lines and rats: the effect of mucus on particle adsorption and transport. Pharm Res 2002, 19:1185-1193.
21. Grenha A., Remuñán-López C., Carvalho E.L., Seijo B. Microspheres containing lipid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins. Eur J Pharm Biopharm 2008, 69:83-93.
22. Brignole-Baudouin F., Riancho L., Liang H., Nakib Z., Baudouin C. In vitro comparative toxicology of polyquad-preserved and benzalkonium chloride-preserved travoprost/timolol fixed combination and latanoprost/timolol fixed combination. J Ocul Pharmacol Th 2011, 27:273-280.
23. Diebold Y., Jarrín M., Sáez V., Carvalho E.L., Orea M., Calonge M., et al. Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP). Biomaterials 2007, 28:1553-1564.
24. Enríquez de Salamanca A., Diebold Y., Calonge M., García-Vazquez C., Callejo S., Vila A., et al. Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance. Invest Ophthalmol Vis Sci 2006, 47:1416-1425.
25. Kuai R., Yuan W., Qin Y., Chen H., Tang J., Yuan M., et al. Efficient delivery of payload into tumor cells in a controlled manner by TAT and thiolytic cleavable PEG co-modified liposomes. Mol Pharm 2010, 7:1816-1826.
26. Hu Q., Wang J., Shen J., Liu M., Jin X., Tang G., et al. Intracellular pathways and nuclear localization signal peptide-mediated gene transfection by cationic polymeric nanovectors. Biomaterials 2012, 33:1135-1145.
27. Peng S.F., Tseng M.T., Ho Y.C., Wei M.C., Liao Z.X., Sung H.W. Mechanisms of cellular uptake and intracellular trafficking with chitosan/DNA/poly(γ-glutamic acid) complexes as a gene delivery vector. Biomaterials 2011, 32:239-248.
28. Liu C., Yu W., Chen Z., Zhang J., Zhang N. Enhanced gene transfection efficiency in CD13-positive vascular endothelial cells with targeted poly(lactic acid)-poly(ethylene glycol) nanoparticles through caveolae-mediated endocytosis. J Control Release 2011, 151:162-175.
29. Zhao X., Yin L., Ding J., Tang C., Gu S., Yin C., et al. Thiolated trimethyl chitosan nanocomplexes as gene carriers with high in vitro and in vivo transfection efficiency. J Control Release 2010, 144:46-54.
30. Chiu Y.L., Ho Y.C., Chen Y.M., Peng S.F., Ke C.J., Chen K.J., et al. The characteristics, cellular uptake and intracellular trafficking of nanoparticles made of hydrophobically-modified chitosan. J Control Release 2010, 146:152-159.
31. Xiong X.B., Uludaĝ H., Lavasanifar A. Biodegradable amphiphilic poly(ethylene oxide)-block-polyesters with grafted polyamines as supramolecular nanocarriers for efficient siRNA delivery. Biomaterials 2009, 30:242-253.
32. Perumal O.P., Inapagolla R., Kannan S., Kannan R.M. The effect of surface functionality on cellular trafficking of dendrimers. Biomaterials 2008, 29:3469-3476.
33. Li P., Li D., Zhang L., Li G., Wang E. Cationic lipid bilayer coated gold nanoparticles-mediated transfection of mammalian cells. Biomaterials 2008, 29:3617-3624.
34. Patnaik S., Aggarwal A., Nimesh S., Goel A., Ganguli M., Saini N., et al. PEI-alginate nanocomposites as efficient in vitro gene transfection agents. J Control Release 2006, 114:398-409.
35. Goyal R., Tripathi S.K., Tyagi S., Ravi Ram K., Ansari K.M., Shukla Y., et al. Gum blended PEI nanocomposites as gene delivery agents: evidences from in vitro and in vivo studies. Eur J Pharm Biopharm 2009, 79:3-14.
36. Wang B., He C., Tang C., Yin C. Effects of hydrophobic and hydrophilic modifications on gene delivery of amphiphilic chitosan based nanocarriers. Biomaterials 2011, 32:4630-4638.
37. Thevenot J., Troutier Al, Putaux Jl, Delair T., Ladaviere C. Effect of the polymer nature on the structural organization of lipid/polymer particle assemblies. J Phys Chem B 2008, 112:13812-13822.
38. Gumbleton M., Abulrob A.G., Campbell L. Caveolae: an alternative membrane transport compartment. Pharm Res 2000, 17:1035-1048.
39. Simons K., Ikonen E. Functional rafts in cell membranes. Nature 1997, 387:569-572.
40. Wang L.H., Rothberg K.G., Anderson R.G. Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J Cell Biol 1993, 123:1107-1117.
41. Kawakami S., Suzuki S., Yamashita F., Hashida M. Induction of apoptosis in A549 human lung cancer cells by all-trans retinoic acid incorporated in DOTAP/cholesterol liposomes. J Control Release 2006, 110:514-521.
42. Lee Y., Lee S.H., Kim J.S., Maruyama A., Chen X., Park T.G. Controlled synthesis of PEI-coated gold nanoparticles using reductive catechol chemistry for siRNA delivery. J Control Release 2011, 155:3-10.
43. Taylor K.M.G., Morris R.M. Thermal-Analysis of phase-transition behavior in liposomes. Thermochimica Acta 1995, 248:289-301.
44. Verma A., Stellacci F. Effect of surface properties on nanoparticle-cell interactions. Small 2010, 6:12-21.
45. Win K.Y., Feng S.S. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 2005, 26:2713-2722.
46. Chung Y.I., Kim J.C., Kim Y.H., Tae G., Lee S.Y., Kim K., et al. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated pluronic on tumor targeting. J Control Release 2010, 143:374-382.
47. Child P., Kuksis A. Investigation of the role of micellar phospholipid in the preferential uptake of cholesterol over sitosterol by dispersed rat jejunal villus cells. Biochem Cell Biol 1986, 64:847-853.
48. Kim A., Hanes J. The emergence of multiple particle tracking in intracellular trafficking of nanomedicines. Biophysical Rev 2012, 4:83-92.
49. Gao X., Kim K.S., Liu D. Nonviral gene delivery: what we know and what is next. AAPS J 2007, 9:92-104.
50. Wiethoff C.M., Middaugh C.R. Barriers to nonviral gene delivery. J Pharm Sci 2003, 92:203-217.
51. de la Fuente M., Seijo B., Alonso M.J. Bioadhesive hyaluronan-chitosan nanoparticles can transport genes across the ocular mucosa and transfect ocular tissue. Gene Ther 2008, 15:668-676.
52. Liaw J., Chang S.F., Hsiao F.C. In vivo gene delivery into ocular tissues by eye drops of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) polymeric micelles. Gene Ther 2001, 8:999-1004.